Identification of fused pyrimidines as interleukin 17 secretion inhibitors
Author:
Funder
Open Innovation Drug Discovery
Publisher
Elsevier BV
Subject
Organic Chemistry,Drug Discovery,Pharmacology,General Medicine
Reference42 articles.
1. IL-17 cytokines in immunity and inflammation;Jin;Emerg. Microb. Infect.,2013
2. Interleukin-17A: a unique pathway in immune-mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis;Kirkham;Immunology,2014
3. Discovery of imidazo[1,5-α]pyridines and -pyrimidines as potent and selective RORc inverse agonists;Fauber;Bioorg. Med. Chem. Lett,2015
4. Benzoxazepines achieve potent suppression of IL-17 release in human T-helper 17 (TH17) cells through an Induced-fit binding mode to the nuclear receptor RORγ;Olsson;ChemMedChem,2016
5. Pharmacological inhibitory profile of TAK-828F, a potent and selective orally available RORγt inverse agonist;Shibata;Biochem. Pharmacol.,2018
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Promotion of Water as Solvent in Amination of 4-Chloropyrrolopyrimidines and Related Heterocycles under Acidic Conditions;ACS Omega;2024-03-12
2. Pyrrolopyrimidine based CSF1R inhibitors: Attempted departure from Flatland;European Journal of Medicinal Chemistry;2024-02
3. The Application of Pyrrolo[2, 3-d]pyrimidine Scaffold in Medicinal Chemistry from 2017 to 2021;Mini-Reviews in Medicinal Chemistry;2023-06
4. Synthesis and Development of Highly Selective Pyrrolo[2,3-d]pyrimidine CSF1R Inhibitors Targeting the Autoinhibited Form;Journal of Medicinal Chemistry;2023-05-16
5. Negishi Cross‐Coupling in the Preparation of Benzyl Substituted Pyrrolo[2,3‐d]pyrimidine Based CSF1R Inhibitors;European Journal of Organic Chemistry;2023-03-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3